Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ultra V is a prominent South Korean medical aesthetic company specializing in advanced anti-aging solutions and regenerative medicine. The company is globally recognized for pioneering the Ultra V Lift, a non-surgical procedure utilizing polydioxanone (PDO) and polycaprolactone (PCL) lifting threads to treat skin laxity. A key innovation in their portfolio is UltraCol, the world's first PDO-based microsphere filler designed to stimulate natural collagen production while providing volume. Beyond injectables, Ultra V develops high-performance cosmeceuticals, most notably its Idebenone-based skincare line which leverages potent antioxidant properties. The company maintains a significant international presence, exporting medical devices and aesthetic technologies to over 60 countries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ultra V Medical Aesthetic.